Estrogen receptor-alpha (ERα) is a key factor in the development of breast cancer in humans. The expression and activity of ERα is regulated by a multitude of intracellular and extracellular signals. Here we show a cross-talk between β-catenin and ERα in human breast cancer cells. Knockdown of β-catenin by RNAi resulted in significant reduction of ERα mRNA and/or protein levels in MCF-7, T-47D, and BT-474 breast cancer cells and in significant reduction of estradiol-induced expression of the ERα target genes pS2 and GREB1. In addition β-catenin silencing resulted in significant decrease of growth of MCF-7 cells both in the absence and presence of estradiol. β-catenin and ERα could not be co-immunoprecipitated by ERα antibodies from lysates ...
Epithelial-mesenchymal transition (EMT) has a critical role in tumor progression and has been correl...
Background. Estrogen and its two receptors, estrogen receptor-α and –β (ER-α and ER-β) play an impor...
The estrogen receptor (ER) is expressed in approximately 70% of sporadic breast cancers and is belie...
Although ERBB2 amplification and overexpression is correlated with poor outcome in breast cancer, th...
Abstract Estrogen is a steroid hormone that has critical roles in reproductive development, bone hom...
The role of ERα in hormone responsive breast cancer is well established but that of ERβ remains to b...
Estrogen receptors have pivotal roles in breast cancer growth and progression. ER\u3b1 has been clea...
Estrogen receptors (ERα and ERβ) are ligand-activated transcription factors that play different role...
β-catenin is involved in cell adhesion through catenin-cadherin complexes and as a transcriptional r...
Many studies have investigated the relationship between the E-cadherin/catenin axis and breast cance...
Using messenger RNA (mRNA) in situ hybridization, we investigated estrogen receptor-β (ERβ) mRNA lev...
Estrogen signaling regulates various physiological processes within the female reproductive, cardiov...
Estrogen receptors (ERs) and the PTEN-Akt-mTor pathway are important growth regulators in human brea...
Studies indicate that estrogen receptor (ER) mediates breast cancer-promoting effects of estrogens...
Breast cancer is the most common malignancy in women in the Western world, accounting for 18% of all...
Epithelial-mesenchymal transition (EMT) has a critical role in tumor progression and has been correl...
Background. Estrogen and its two receptors, estrogen receptor-α and –β (ER-α and ER-β) play an impor...
The estrogen receptor (ER) is expressed in approximately 70% of sporadic breast cancers and is belie...
Although ERBB2 amplification and overexpression is correlated with poor outcome in breast cancer, th...
Abstract Estrogen is a steroid hormone that has critical roles in reproductive development, bone hom...
The role of ERα in hormone responsive breast cancer is well established but that of ERβ remains to b...
Estrogen receptors have pivotal roles in breast cancer growth and progression. ER\u3b1 has been clea...
Estrogen receptors (ERα and ERβ) are ligand-activated transcription factors that play different role...
β-catenin is involved in cell adhesion through catenin-cadherin complexes and as a transcriptional r...
Many studies have investigated the relationship between the E-cadherin/catenin axis and breast cance...
Using messenger RNA (mRNA) in situ hybridization, we investigated estrogen receptor-β (ERβ) mRNA lev...
Estrogen signaling regulates various physiological processes within the female reproductive, cardiov...
Estrogen receptors (ERs) and the PTEN-Akt-mTor pathway are important growth regulators in human brea...
Studies indicate that estrogen receptor (ER) mediates breast cancer-promoting effects of estrogens...
Breast cancer is the most common malignancy in women in the Western world, accounting for 18% of all...
Epithelial-mesenchymal transition (EMT) has a critical role in tumor progression and has been correl...
Background. Estrogen and its two receptors, estrogen receptor-α and –β (ER-α and ER-β) play an impor...
The estrogen receptor (ER) is expressed in approximately 70% of sporadic breast cancers and is belie...